Shona Lang

Shona has gained experience working across a range of therapeutic areas including oncology, macular disease, multiple sclerosis, cardiovascular disease, genetic biomarkers, and rare diseases. Her expertise covers all areas of systematic review methodology and also includes diagnostic reviews, rapid reviewcritical appraisal, burden of illness, epidemiology, treatment patterns, statistical reviewing, meta-analysis, and network meta-analysis.  

She has worked in Evidence Review Groups providing single technology appraisals and diagnostic assessment reports for National Institute for Health and Care Excellence (NICE). 

Shona spent 15 years researching cancer cell biology. During her time in the laboratory she worked closely with NHS clinicians and pathologists. She brings her insight of preclinical models, genomics, stem cells, gene therapy, and genetic biomarkers to support evidence generation in emerging technologies. She maintains a strong interest in the application of evidence-based decisionmaking to preclinical research and believes this will enhance the success of clinical and therapeutic research. 

Shona has a PhD in Cancer Studies from the University of Edinburgh.